Here's what is coming soon to Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see soon on Diagnostic Imaging:
In our continued coverage of Breast Cancer Awareness month, breast imaging radiologist, Daniel Shekleton, M.D., from Raleigh Radiology in North Carolina examines recent investigations in the United Kingdom into the effects of launching annual mammography screening at age 40, underscoring the recommendations from the American College of Radiology and the Society of Breast Imaging. Look for his article later this week.
To read insights from his clinical colleague on breast imaging during COVID-19, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Staying knowledgeable of how a woman’s breast density affects imaging is critical, and knowing whether a patient has dense breast can influence your use of preoperative MRI. Investigators from University of Pennsylvania have examined in what circumstances this modality and technique works best. We explore their findings in an article that will appear later this week.
See our previous coverage of breast MRI here.
Corporatization is not new in radiology, but the trend is definitely growing. Diagnostic Imaging spoke this week with Dr. Rich Heller, associate chief medical officer, and Dr. Nina Kottler, vice president of clinical operations, with Radiology Partners about how corporatization benefits radiology as an industry and the impacts it can have at the local level. Keep an eye out for their video interview this week.
To view Diagnostic Imaging’s other video content, click here.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.